This site is intended for healthcare professionals only
Share this article

Managing glycaemia in people with type 2 diabetes and renal impairment: An update for clinical practice

This supplement was initiated and fully funded by Novo Nordisk.

Adverse event reporting and prescribing information for Victoza® (liraglutide) can be found within the supplement. 

The content has been reviewed and approved by the sponsoring company and the authors prior to publication. Editorial support for this supplement was provided by SB Communications Group. 
Job code: UK/VT/0615/0336  Date of preparation: July 2015

Share this article
For the latest news and articles

Sign up to all DiabetesontheNet journals

© Copyright Omniamed Communications. All Rights Reserved​
108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom​
Omniamed logo white
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals


By clicking ‘Subscribe’, you are agreeing that are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

DiabetesontheNet Logo

This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.